John's wort, and curcumin
Lilly and Novo are racing to bring oral GLP-1 treatments to market
The honest summary: the evidence is stronger than most people realize, and it is good enough that we consider this a legitimate clinical tool, not just a supplement people are asking about
Awasthi YC, Sharma R, Cheng JZ et al (2003) Role of 4-hydroxynonenal in stress-mediated apoptosis signaling
For female patients, hormonal status, lean muscle percentage, and liver function further shape optimal dosing
The cost of GLP-1 medications to treat obesity has helped drive large increases in pharmacy trends over the last three years, and despite the clear clinical benefits of this drug class, some employers and plan sponsors have chosen to discontinue coverage due to cost concerns